melevodopa Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Melevodopa is a dopaminergic agent. It is the methyl ester of levodopa. It is used in tablet form as an effervescent prodrug with 250 times the water solubility of tablet levodopa.   Wikipedia

Chemistry

  • SMILES: COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1
  • InChIKey: XBBDACCLCFWBSI-ZETCQYMHSA-N
  • Mol. Mass: 211.22
  • ALogP: 0.14
  • ChEMBL Molecule:
    melevodopa  
More Chemistry

Pharmacology

Alternative names

dl-dopa methyl ester | dopa methyl ester, (d)-isomer | l-dopa methyl ester | levodopa methyl ester | levodopa methyl ester hydrochloride | levodopa methyl ester hydrochloride, (dl)-isomer | levomet | melevodopa | methyl l-dopa | v1512

Organizations (4)

Research & Development (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Parkinson Disease (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial Organizations: 4

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue